Merus N V 's ability to collect accounts receivable sequentially worsen to 4.39, pointing to a challenging and on top of that deteriorating business climate for the Major Pharmaceutical Preparations industry. Merus N V 's Accounts Receivable average collection period in the Sep 30 2025 quarter, has increased to 83 days, from 54 days, in the Jun 30 2025 quarter.

If we take a look into Healthcare sector 389 other companies have achieved higher receivables turnover ratio. While total ranking has deteriorated relative to the period ending Sep 30 2025 from 1826 to 2666.

What is Receivable Turnover Ratio?
What is Merus N V Selling?

What is Receivable Turnover Ratio?

Select the Comparisons :

None ▼

Select the Ratio:

Accounts Receivables Turnover▼

None ▼

Accounts Receivables Turnover▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

MRUS Receivables Turnover Ratio	(Sep 30 2025) III. Quarter	(Jun 30 2025) II. Quarter	(Mar 31 2025) I. Quarter	(Dec 31 2024) IV. Quarter	(Sep 30 2024) III. Quarter
Y / Y Receivable Change	1591.53 %	816.88 %	-75.81 %	-48.09 %	-66.98 %
Y / Y Revenue Change	3.21 %	20.4 %	235.76 %	2.25 %	6.7 %
Receivable Turnover Ratio (TTM)	4.39	6.72	11.87	2.3	2.24
MRUS's Total Ranking	# 2666	# 1826	# 1826	# 2431	# 2754
Accounts Receivable average collection period days	83	54	31	159	163
Seq. Receivable Change	13.58 %	18.91 %	1026.33 %	11.2 %	-38.44 %
Seq. Revenue Change	37.63 %	-66.67 %	189.8 %	-22.36 %	60.56 %

Receivable Turnover Company Ranking
Within:	No.
Major Pharmaceutical Preparations Industry	# 117
Healthcare Sector	# 390
Overall Market	# 2666

Receivable Turnover Ratio Statistics
High	Average	Low
16.73	10.48	2.12
(Mar 31 2021)		(Jun 30 2024)

MRUS Company Profile • Back to MRUS Efficiency Comparisons • Compare MRUS Receivables Turnover Ratio to its Competitors

Financial Statements
Merus N V 's Accounts Receivable	$ 19 Millions	Visit MRUS's Balance sheet
Merus N V 's Sales TTM	$ 57 Millions	Visit MRUS's Income Statement
Sources of MRUS's Revenues		Visit MRUS's Sales by Geography

Other Accounts Receivable Turnover Ratios
Major Pharmaceutical Preparations Industry Accounts Receivable Turnover Trends and Statistics
Healthcare Sector Accounts Receivable Turnover Statistics
Accounts Receivables Turnover Trends for overall market
MRUS's Receivable Turnover Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Accounts Receivables Turnover
Lowest Ranking Accounts Receivables Turnover

You may also want to know
MRUS's Growth Rates	MRUS's Roa	MRUS's Inventory Turnover Ratio	MRUS's Dividend Comparisons
MRUS's Profitability Ratios	MRUS's Roi	MRUS's Asset Turnover Ratio	MRUS's Dividend Growth
MRUS's Valuation Ratios	MRUS's Roe	MRUS's Financial Strength Ratios	MRUS's Dividend Payout Ratio

Companies with similar Receivables Turnover Ratio for the quarter ending Sep 30 2025, within Healthcare Sector	Receivable Turnover Ratio	Revenues for 12 Months ending Sep 30 2025	Receivable at quarter ending Sep 30 2025
Jaguar Health Inc	8.05	$ 11.785 Millions	$ 1.464 Millions
Henry Schein Inc	8.03	$ 12,938.000 Millions	$ 1,612.000 Millions
Alphatec Holdings Inc	7.98	$ 728.985 Millions	$ 91.306 Millions
Exelixis Inc	7.96	$ 2,288.218 Millions	$ 287.288 Millions
Pediatrix Medical Group Inc	7.91	$ 1,922.442 Millions	$ 243.158 Millions
Sotera Health Company	7.89	$ 1,149.979 Millions	$ 145.672 Millions
Protalix Biotherapeutics inc	7.86	$ 61.840 Millions	$ 7.863 Millions
Axogen inc	7.86	$ 214.708 Millions	$ 27.301 Millions
Grail Inc	7.86	$ 141.827 Millions	$ 18.054 Millions
Alpha Teknova Inc	7.84	$ 39.573 Millions	$ 5.051 Millions
Idexx Laboratories Inc	7.83	$ 4,166.125 Millions	$ 532.121 Millions
Day One Biopharmaceuticals Inc	7.83	$ 133.672 Millions	$ 17.074 Millions
Myomo Inc	7.82	$ 40.719 Millions	$ 5.209 Millions
Semler Scientific inc	7.78	$ 36.957 Millions	$ 4.752 Millions
Quest Diagnostics Inc	7.77	$ 10,850.000 Millions	$ 1,395.750 Millions
Intuitive Surgical Inc	7.73	$ 9,610.200 Millions	$ 1,243.950 Millions
Aveanna Healthcare Holdings Inc	7.71	$ 2,290.591 Millions	$ 297.282 Millions
Indivior Pharmaceuticals Inc	7.70	$ 2,068.000 Millions	$ 268.500 Millions
Novocure Limited	7.69	$ 642.269 Millions	$ 83.470 Millions
Penumbra Inc	7.68	$ 1,333.798 Millions	$ 173.654 Millions
Twist Bioscience Corporation	7.68	$ 376.572 Millions	$ 49.034 Millions
Regenxbio Inc	7.66	$ 161.318 Millions	$ 21.053 Millions
Guardant Health Inc	7.66	$ 902.569 Millions	$ 117.879 Millions
Jin Medical International Ltd	7.65	$ 20.687 Millions	$ 2.706 Millions
Vycor Medical Inc	7.58	$ 1.902 Millions	$ 0.251 Millions
Cue Biopharma Inc	7.55	$ 7.100 Millions	$ 0.941 Millions
Biolife Solutions Inc	7.54	$ 74.005 Millions	$ 9.809 Millions
Pacs Group Inc	7.54	$ 5,138.841 Millions	$ 681.562 Millions
Becton Dickinson And Company	7.53	$ 21,840.000 Millions	$ 2,901.000 Millions
Sight Sciences Inc	7.53	$ 74.439 Millions	$ 9.892 Millions

Date modified: 2026-06-23T19:22:37+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.